Literature DB >> 9838075

Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats.

E Escubedo1, L Guitart, F X Sureda, A Jiménez, D Pubill, M Pallàs, A Camins, J Camarasa.   

Abstract

Chronic administration of methamphetamine to rats induces neurotoxicity characterized by a loss of striatal dopaminergic terminals and reactive gliosis. Subcutaneous administration of methamphetamine in a scheduled procedure of four doses (10 mg/kg) at 2 h interval also induces a significant increase in the peripheral-type benzodiazepine receptor (PBR) density. This increase is maximum (76%) at 72 h post-treatment in the striatum and disappears at 7 days, suggesting that microglia may have a predominant role in necrosis-phagocytosis of neuronal debris rather than acting in a restorative manner. Microgliosis is not restricted to the striatum since it is also evident in cerebellum (75.4% of PBR increase) and hippocampus (37.2% of PBR increase). In the areas with high density of adenosine transporter, the microgliosis phenomenon correlates well with a decrease of this nucleoside transporter (about 39%). Although the microgliosis and the decrease in adenosine transporter could be parallel and not related events, we can speculate that when microglia are activated, a down-regulation of adenosine transporter occurs, playing a role in tissue homeostasis. With the same dosing schedule, methamphetamine induces HSP72 expression in both cytoplasmic and nuclear fractions of the striatum, cerebellum and hippocampus. This expression is also evident in the cerebral cortex, where adenosine transporter population did not show any variation. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9838075     DOI: 10.1016/s0006-8993(98)01065-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

Review 1.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

Review 2.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

3.  Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.

Authors:  David Pubill; Anna M Canudas; Mercè Pallàs; Antonio Camins; Jorge Camarasa; Elena Escubedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-09       Impact factor: 3.000

4.  Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine.

Authors:  Hongxian Chen; Jin Wu; Jichun Zhang; Yuko Fujita; Tamaki Ishima; Masaomi Iyo; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2011-12-27       Impact factor: 4.530

Review 5.  Role of microglia in methamphetamine-induced neurotoxicity.

Authors:  Enquan Xu; Jianuo Liu; Han Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

Review 6.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

7.  Mir143-BBC3 cascade reduces microglial survival via interplay between apoptosis and autophagy: Implications for methamphetamine-mediated neurotoxicity.

Authors:  Yuan Zhang; Kai Shen; Ying Bai; Xuan Lv; Rongrong Huang; Wei Zhang; Jie Chao; Lan K Nguyen; Jun Hua; Guangming Gan; Gang Hu; Honghong Yao
Journal:  Autophagy       Date:  2016-07-27       Impact factor: 16.016

8.  The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine.

Authors:  Matthew G Frank; Sweta Adhikary; Julia L Sobesky; Michael D Weber; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2015-08-04       Impact factor: 7.217

Review 9.  The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.

Authors:  Bryan K Yamamoto; Jamie Raudensky
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-15       Impact factor: 4.147

10.  White-matter abnormalities in brain during early abstinence from methamphetamine abuse.

Authors:  Marc C Tobias; Joseph O'Neill; Matthew Hudkins; George Bartzokis; Andrew C Dean; Edythe D London
Journal:  Psychopharmacology (Berl)       Date:  2010-01-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.